Global proteomic analysis deciphers the mechanism of action of plant derived oleic acid against Candida albicans virulence and biofilm formation | Scientific Reports
Targeting adhesion in fungal pathogen Candida albicans | Future Medicinal Chemistry
and Bernhard Proteinases in Virulence and Pathogenesis Secreted Aspartyl Candida albicans | Semantic Scholar
HIV-Protease Inhibitors Reduce Cell Adherence of Candida Albicans Strains by Inhibition of Yeast Secreted Aspartic Proteases - ScienceDirect
JoF | Free Full-Text | Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo Approaches
HIV-Protease Inhibitors Reduce Cell Adherence of Candida Albicans Strains by Inhibition of Yeast Secreted Aspartic Proteases - ScienceDirect
Secreted aspartyl proteinase (PbSap) contributes to the virulence of Paracoccidioides brasiliensis infection | PLOS Neglected Tropical Diseases
JoF | Free Full-Text | Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo Approaches
HIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos Santos
Catechol thwarts virulent dimorphism in Candida albicans and potentiates the antifungal efficacy of azoles and polyenes | Scientific Reports
JoF | Free Full-Text | Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo Approaches
Screening of Compounds from an FDA-Approved Drug Library for the Ability to Inhibit Aspartic Protease Secretion from the Pathoge
HIV-Protease Inhibitors Reduce Cell Adherence of Candida Albicans Strains by Inhibition of Yeast Secreted Aspartic Proteases - ScienceDirect
General targets of natural antifungal protease inhibitors: Protease... | Download Scientific Diagram
Re-emerging Aspartic Protease Targets: Examining Cryptococcus neoformans Major Aspartyl Peptidase 1 as a Target for Antifungal Drug Discovery | Journal of Medicinal Chemistry
Global Secretome Characterization of the Pathogenic Yeast Candida glabrata | Journal of Proteome Research
Frontiers | Mechanisms of Pathogenic Candida Species to Evade the Host Complement Attack
Molecular docking of the bioactive compound Ocimum sanctum as an inhibitor of Sap 1 Candida albicans | Sasambo Journal of Pharmacy
JoF | Free Full-Text | Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo Approaches
Candida SAP - The Parapharmacy
PDF) Aspartic Protease Inhibitors: Effective Drugs against the Human Fungal Pathogen Candida albicans | Mini-Reviews in Medicinal Chemistry MRMC and Andre Santos - Academia.edu
JoF | Free Full-Text | Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo Approaches
Protease expression by microorganisms and its relevance to crucial physiological/pathological events
